Mabuterol
Mabuterol is a selective β2 adrenoreceptor agonist.[1][2]
Clinical data | |
---|---|
Other names | Mabuterolum; PB 868Cl |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C13H18ClF3N2O |
Molar mass | 310.75 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
See also
References
- Osada, E; Murai, T; Ishizaka, Y; Sanai, K (1984). "Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs". Arzneimittel-Forschung. 34 (11A): 1641–51. PMID 6152157.
- Akahane K, Furukawa Y, Ogiwara Y, Haniuda M, Chiba S (July 1989). "Beta-adrenoceptor blocking effects of a selective beta 2-agonist, mabuterol, on the isolated, blood-perfused right atrium of the dog". Br. J. Pharmacol. 97 (3): 709–16. doi:10.1111/j.1476-5381.1989.tb12007.x. PMC 1854580. PMID 2474351.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.